143 related articles for article (PubMed ID: 19461898)
1. Correlation of Plasma Protein Carbonyls and C-Reactive Protein with GOLD Stage Progression in COPD Patients.
Torres-Ramos YD; García-Guillen ML; Olivares-Corichi IM; Hicks JJ
Open Respir Med J; 2009 Apr; 3():61-6. PubMed ID: 19461898
[TBL] [Abstract][Full Text] [Related]
2. RBC membrane damage and decreased band 3 phospho-tyrosine phosphatase activity are markers of COPD progression.
Torres-Ramos YD; Guzman-Grenfell AM; Montoya-Estrada A; Ramirez-Venegas A; Martinez RS; Flores-Trujillo F; Ochoa-Cautino L; Hicks JJ
Front Biosci (Elite Ed); 2010 Jun; 2(4):1385-93. PubMed ID: 20515811
[TBL] [Abstract][Full Text] [Related]
3. Increased oxidative stress and altered levels of nitric oxide and peroxynitrite in Tunisian patients with chronic obstructive pulmonary disease: correlation with disease severity and airflow obstruction.
ben Anes A; Fetoui H; Bchir S; ben Nasr H; Chahdoura H; Chabchoub E; Yacoub S; Garrouch A; Benzarti M; Tabka Z; Chahed K
Biol Trace Elem Res; 2014 Oct; 161(1):20-31. PubMed ID: 25074430
[TBL] [Abstract][Full Text] [Related]
4. Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.
Biljak VR; Rumora L; Cepelak I; Pancirov D; Popović-Grle S; Sorić J; Stjepanović G; Grubisić TZ
Coll Antropol; 2013 Mar; 37(1):221-7. PubMed ID: 23697277
[TBL] [Abstract][Full Text] [Related]
5. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease.
Nadeem A; Raj HG; Chhabra SK
Inflammation; 2005 Feb; 29(1):23-32. PubMed ID: 16502343
[TBL] [Abstract][Full Text] [Related]
6. Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.
Ben Anes A; Ben Nasr H; Garrouch A; Bennour S; Bchir S; Hachana M; Benzarti M; Tabka Z; Chahed K
Mol Cell Biochem; 2018 Aug; 445(1-2):1-11. PubMed ID: 29234928
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation.
Stanojkovic I; Kotur-Stevuljevic J; Milenkovic B; Spasic S; Vujic T; Stefanovic A; Llic A; Ivanisevic J
Respir Med; 2011 Oct; 105 Suppl 1():S31-7. PubMed ID: 22015083
[TBL] [Abstract][Full Text] [Related]
8. [Correlations between lipid ratio/oxidative stress status in COPD patients and pulmonary hypertension
as well as prognosis].
Li C; Yan L; Xu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1168-1174. PubMed ID: 27932762
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between nutritional status and oxidative stress markers, pulmonary function in patients with stable chronic obstructive pulmonary disease].
Jiang XL; Zhong P; Huang CL; He F; Fan XM; Chen XR
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):40-45. PubMed ID: 28100361
[No Abstract] [Full Text] [Related]
10. Increased Serum Romo1 Was Correlated with Lung Function, Inflammation, and Oxidative Stress in Chronic Obstructive Pulmonary Disease.
Ye L; Mao S; Fang S; Zhang J; Tan Y; Gu W
Inflammation; 2019 Oct; 42(5):1555-1560. PubMed ID: 31049771
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Oxidative Stress and Ammonia According to the Different Grades of Hepatic Encephalopathy.
Montes-Cortes DH; Olivares-Corichi IM; Rosas-Barrientos JV; Manuel-Apolinar L; Martìnez-Godinez MLA; Hernández-López JC; Cruz-Dominguez MDP
Dig Dis; 2020; 38(3):240-250. PubMed ID: 31578013
[TBL] [Abstract][Full Text] [Related]
12. The role of oxidative stress in the pathogenesis of COPD: implications for therapy.
Rahman I
Treat Respir Med; 2005; 4(3):175-200. PubMed ID: 15987234
[TBL] [Abstract][Full Text] [Related]
13. [Effects of PM2.5 on phagocytic function of alveolar macrophages in chronic obstructive pulmonary disease mice].
Shu J; Liu X; Chu X; Qiu J; Zeng X; Bao H
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(4):301-5. PubMed ID: 26879794
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in patients with COPD and pulmonary hypertension.
Joppa P; Petrásová D; Stancák B; Dorková Z; Tkácová R
Wien Klin Wochenschr; 2007; 119(13-14):428-34. PubMed ID: 17671825
[TBL] [Abstract][Full Text] [Related]
15. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
16. [Effects of exposure to ambient particulate matter and polycyclic aromatic hydrocarbons on oxidative stress biomarkers in the patients with chronic obstructive pulmonary disease].
Zhang Y; Song XM; Zhao Q; Wang T; Li LJ; Chen J; Xu HB; Liu BB; Sun XY; He B; Huang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):394-402. PubMed ID: 28628138
[TBL] [Abstract][Full Text] [Related]
17. The Cu/Zn superoxide dismutase +35A/C (rs2234694) variant correlates with altered levels of protein carbonyls and glutathione and associates with severity of COPD in a Tunisian population.
Ben Anes A; Ben Nasr H; Garrouche A; Bchir S; Dhaouefi Z; Chabchoub E; Tabka Z; Chahed K
Free Radic Res; 2019 Mar; 53(3):293-303. PubMed ID: 30668180
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Scand J Immunol; 2017 Feb; 85(2):130-137. PubMed ID: 28256060
[TBL] [Abstract][Full Text] [Related]
19. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
20. Circulating malondialdehyde concentrations in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Paliogiannis P; Fois AG; Sotgia S; Mangoni AA; Zinellu E; Pirina P; Carru C; Zinellu A
Biomark Med; 2018 Jul; 12(7):771-781. PubMed ID: 29865860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
